Ozempic has become a popular treatment for type 2 diabetes and weight loss. Discover how it works, its benefits, and ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

Weight loss tops many folks' list of New Year's resolutions, and lots of people are turning to cutting-edge weight-loss drugs ...

The following is a summary of “Association of Perioperative Glucagon-like Peptide-1 Receptor Agonist Use and Postoperative ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

this GLP-1 (glucagon-like peptide 1 receptor agonist) medication helps reduce appetite and curb food cravings. This leaves many wondering what to eat on Ozempic (semaglutide). Whether you’re ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose ...